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Abstract
There is emerging evidence that esophageal cancer occurs in younger adults in
sub-Saharan Africa than in Europe or North America. The burden of human
immunodeficiency virus (HIV) is also high in this region. We postulated that
HIV and human papillomavirus (HPV) infections might contribute to esopha-
geal squamous cell carcinoma (OSCC) risk. This was a case–control study based
at the University Teaching Hospital in Lusaka, Zambia. Cases were patients
with confirmed OSCC and controls had completely normal upper endoscopic
evaluations. A total of 222 patients were included to analyze the influence of
HIV infection; of these, 100 patients were used to analyze the influence of HPV
infection, alcohol, smoking, and exposure to wood smoke. The presence of HIV
infection was determined using antibody kits, and HPV infection was detected
by polymerase chain reaction. HIV infection on its own conferred increased risk
of developing OSCC (odds ratio [OR] 2.3; 95% confidence interval [CI] 1.0–
5.1; P = 0.03). The OR was stronger when only people under 60 years were
included (OR 4.3; 95% CI 1.5–13.2; P = 0.003). Cooking with charcoal or fire-
wood, and cigarette smoking, both increased the odds of developing OSCC
([OR 3.5; 95% CI 1.4–9.3; P = 0.004] and [OR 9.1; 95% CI 3.0–30.4;
P < 0.001], respectively). There was no significant difference in HPV detection
or alcohol intake between cases and controls. We conclude that HIV infection
and exposure to domestic and cigarette smoke are risk factors for OSCC, and
HPV immunization unlikely to reduce OSCC incidence in Zambia.
ª 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of
the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
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Introduction
Esophageal cancer is the eighth most common cancer glob-
ally and the sixth most common cause of cancer deaths [1].
Southern Africa has the second highest incidence and
mortality rates of esophageal cancer in the world [1], which
makes it one of the major cancer burdens in the region. In
Zambia, available registry data suggest that esophageal
cancer is the fifth most common cancer, and is ranked
fourth among the causes of cancer deaths [2].
Despite a well described increase in adenocarcinoma,
esophageal squamous cell carcinoma (OSCC) remains the
predominant type of esophageal cancer worldwide [3, 4].
There has been a steady increase in esophageal cancer
cases in sub-Saharan Africa [5, 6], although it is not clear
if this is a real increase or a reflection of improved case
detection. Esophageal cancer in sub-Saharan Africa devel-
ops at a considerably younger age than in other regions
[7, 8], and we reported that up to 27% of esophageal
cancer patients seen in Zambia were below the age of
45 years [7]. The risk factors for esophageal cancer in
these young adults have not been established.
Sub-Saharan Africa is considered home to more than
60% of all human immunodeficiency virus (HIV)-infected
people [9], and in Zambia the prevalence of HIV infec-
tion is 12.7% [10]. The involvement of HIV infection in
the development of SCC is uncertain. An analysis of reg-
istry data in the United States showed that the risk of
developing esophageal cancer is higher among AIDS
patients (standardized incidence ratio = 1.69; 95% confi-
dence interval [CI], 1.37–2.07) [11], although the mecha-
nism by which this occurs is not clear. There is also
evidence that persons living with HIV infection are gener-
ally more susceptible to cancer than the general popula-
tion [12]. In 2009, Mlombe et al. published the findings
of a small study in Malawi that showed increases in both
esophageal cancer and Kaposi’s Sarcoma (an HIV-associ-
ated cancer) [13]. They offered no clear explanation for
this observation, although this could have been due to
HIV infection.
Three meta-analyses have concluded that human papil-
lomavirus (HPV) infection has a role in the development
of esophageal cancer [14–16], but there is also evidence
against such a role [17, 18]. There is little evidence for
the involvement of HPV in esophageal cancer in some
areas in sub-Saharan Africa [19] and in a recent study in
South Africa, HPV was shown to play a minor role in the
pathogenesis of esophageal cancer [20].The prevalence of
esophageal HPV infection in sub-Saharan Africa is
unknown, although it was reported to be 24% among
women with normal cervical cytology [21].
We undertook this case–control study to explore risk
factors of OSCC in Zambia. We focused on HIV and
HPV infections as infective agents that could be inde-
pendently increasing the occurrence of OSCC, especially
among young patients in Zambia. In addition, the life-
style risk factors of smoking, alcohol, and exposure to
wood smoke were evaluated.
Materials and Methods
Study design
This study was conducted at the University Teaching Hospi-
tal (UTH) in Lusaka, Zambia from October 2013 to May
2014. UTH is the only combined secondary and tertiary hos-
pital in the country, and offers full time endoscopy services.
The unit offers standard endoscopic evaluation using high-
definition Pentax London, United Kingdom (EG2990i) gas-
troscopes. Patients attending this unit are referred from all
parts of the country.
Enrollment
All patients attending the unit during the study period were
considered for enrollment. Consent for study participation
was obtained before the endoscopy. Between October 2013
and May 2014, 67 patients with esophageal lesions sus-
pected to be esophageal cancer gave consent to participate
in the study. Of these, 61 had histologically confirmed
esophageal cancer, including 58 (95.1%) OSCC and 3
(4.9%) adenocarcinoma. Adenocarcinoma patients were
excluded from the analysis. Eight esophageal cancer cases
were also excluded due to the unavailability of an appropri-
ate control during the study period. Therefore, 50 OSCC
patients were enrolled and matched by age (3 years) and
sex to 50 controls. Initial analysis showed that the associa-
tion of OSCC with HIV infection was very close to being
significant, which suggested that the sample size was too
small to show an effect. To clarify the influence of HIV
infection, we increased the power of the study by combin-
ing these data with 122 patients (27 cases and 95 controls)
obtained from a preliminary case–control study conducted
at the same unit between July 2011 and January 2012. This
case–control study had the same inclusion and exclusion
criteria as outlined above, but no frozen samples were avail-
able for HPV analysis. With these data sets merged, we con-
ducted further statistical analysis of the HIV effect, as
outlined in the results below. We, therefore, analyzed a
total of 222 patients with 77 cases and 145 controls.
Procedure
During the endoscopy, patients with lesions that were
suspected to be esophageal cancer were designated as
cases. A careful examination of the lesions was performed,
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and its location defined as follows: 15–24 cm, upper
third; 24–32 cm, middle third; and 32–40 cm, lower third
[22]. We also took note of the degree of luminal occlu-
sion. Six biopsies were obtained from these lesions and
sent for histopathology. Status as a study case was only
confirmed after invasive squamous carcinoma was
reported by the team histopathologist (A. S.). Two addi-
tional biopsies were taken from the lesion, immediately
placed in liquid nitrogen, and stored at 80°C for later
determination of the presence of HPV infection. The next
available sex- and age-matched patient (age within 3 years
of the index case) was then enrolled as a control. Controls
were completely normal upper endoscopic evaluations,
and two esophageal biopsies were taken from the mid-
esophagus of controls. As in the cases above, the biopsies
were immediately placed in liquid nitrogen and taken to
the laboratory to be stored at 80°C. We excluded
patients with a history of any form of treatment for
esophageal cancer or those unwilling to have an HIV test.
After the endoscopic procedure, 5–10 mL of venous
blood was drawn from the study participants; serum was
extracted and stored at 80°C for later determination of
the presence of HIV antibodies.
A simple questionnaire was used to collect data on the
lifestyle risk factors for esophageal cancer from both the
cases and the controls. We also collected information
about symptoms that were present.
Histopathology
Six biopsies per participant were placed in formalin and
sent to the histopathology laboratory. These biopsies were
processed to 3 lm sections, stained with hematoxylin and
eosin for 1 h, and then examined using standard diagnos-
tic criteria for OSCC. This included the presence of
nuclear atypia and evidence of invasion.
HIV testing
The frozen sera were thawed to room temperature and
tested for the presence of HIV antibodies with Determine
test kits (Alere Medical Co., Chiba, Japan) following the
manufacturer’s instructions. Unigold (Trinity Biotech plc,
Bray, Ireland) kits were used as a confirmatory test for all
the samples that tested positive with Determine. K. Z.
conducted these tests and she was blinded to the alloca-
tion of the samples.
HPV testing
DNA was extracted from frozen esophageal biopsy speci-
mens using a Qiagen QIAmp DNA Mini Kit (Qiagen,
Valencia, CA), according to the DNA Purification from
Tissues protocol. A final elution volume of 200 lL was
used, and DNA extracts were frozen at 20°C until further
testing. For each specimen, 10 lL was used for the poly-
merase chain reaction (PCR) step of the DNA ELISA kit
HPV SPF10 (LBP, Visseringlaan 25, ER Rijswijk, The Neth-
erlands), which uses biotin-labeled SPF10 primers that tar-
get a conserved 65 bp region of the HPV L1 gene for
broad-spectrum amplification. PCR products were stored
at 4°C for less than 24 h before subsequent analysis. For
each specimen, 10 lL of PCR product was tested in the
SPF10 ELISA and/or SPF10 LiPA25 (LBP) assay, performed
per the manufacturer’s instructions. The ELISA assay uses
streptavidin-coated plates to capture biotin-labelled PCR
products, followed by hybridization with a cocktail of
labelled HPV-specific probes, which is detected with a con-
jugate and visualized by a substrate. The presence or
absence of HPV DNA is determined by comparing the
optical density of the PCR product to a cut-off value.
The LiPA25 is a reverse line blot assay where denatured
PCR products hybridize with specific oligonucleotide
probes immobilized on membrane strips. Following
hybridization and washing, streptavidin-conjugated alka-
line phosphatase binds to biotinylated PCR products,
and bands are visualized by a substrate. Due to limited
ELISA reagents, nine specimens were solely tested using
LiPA. The worker who performed the HPV testing (A.
C. B.) was blinded to the case–control status of all speci-
mens. In addition to kit controls, external quality assur-
ance specimens were used as known positive controls.
Positive controls and negative controls were used for
each step (extraction, amplification, and detection), and
the results of controls were as expected.
Statistical analysis
Data were analyzed using STATA 13 (Stata Corp, Col-
lege Station, TX). For categorical variables, the Fisher’s
exact test was used, and for continuous variables the
Kruskal–Wallis rank tests were used. To analyze the
effect of HIV infection in strictly matched case–control
pairs, we also used McNemar’s test. Odds ratios (ORs)
with 95% CIs were derived to estimate the association
between exposure variables and OSCC. A P value less
than 0.05 was considered statistically significant. Using
STATA, we performed a stepwise unconditional logistic
regression to assess the relative contributions of differ-
ent exposure variables (smoking, alcohol intake, HIV
infection, HPV infection, exposure to household smoke,
educational level, residence, marital status and occupa-
tion) to the risk of developing OSCC.
Ethical approval was obtained from the University of
Zambia Biomedical and Ethics Committee (reference
number 001-06-13).
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Results
Baseline characteristics
The baseline characteristics of the cases and controls were
similar (Table 1). The mean age of the OSCC patients
was 56.2 years, with the youngest patient being 28 years.
The duration of symptoms was significantly shorter
among the cancer cases than the controls (P = 004), as
shown in Table 1.
OSCC characteristics
The full description of esophageal tumor characteristics
was available in 46 of the 50 cases included in the analy-
sis. These results showed that most of the tumors were
either in the upper or the middle part of the esophagus
and had some degree of luminal occlusion (Table 1).
Lifestyle risk factors for squamous cell
carcinoma of the esophagus
Analysis of 50 OSCC cases and 50 controls showed that
cooking with charcoal or firewood within the household
increased the odds of developing OSCC (Tables 1 and 2).
Cigarette smoking (current and past) was also a strong
risk factor for OSCC. There was no association between
OSCC and residence (urban vs. rural), marital status,
educational level or occupation (Table 1).
HPV as a risk factor for OSCC
Of the 92 biopsy samples available for analysis, two cases
and one control were positive for HPV (Table 2). There
was no significant difference in HPV infection between
cases and controls in either univariate or multivariable
analysis.
HIV as a risk factor for OSCC, analyzed using
the combined data set
Initial analysis suggested that there were more HIV-
positive patients among cases than controls particularly
when only patients under the age of 60 years were
included (OR 5.5; 95% CI, 0.9–57; P = 0.04) (Table 2).
To confirm if this important finding could be corrobo-
rated in a larger data set, we then analyzed combined
data (from the current study and previous data) with
an additional 122 records, for a total of 77 OSCC cases
and 145 controls (Table 3). There was no significant
age difference between the two groups, with a median
age of 55 years among the cases and 56 years among
the controls (P = 0.64). There were significantly more
males among the cases (55; 71.4%) than the controls
and (80; 55.1%), P = 0.02. The presence of HIV infec-
tion did not differ between the two sexes, P = 0.852. A
total of 21 (27.3%) cases and 42 (54.5%) controls were
below the age of 45 years (P = 0.88). The presence of
HIV infection did not differ significantly between cases
and controls below the age of 45 years (OR 3.8; 95%
CI, 0.8–20.5; P = 0.07). These data are not shown in
the tables. We also found that 43 (55.8%) cases and 80
(55.1%) controls were below the age of 60 years
(P = 1.00) and there were significantly more HIV-posi-
tive patients among the cases than the controls
(Table 3). We then matched the 77 cases by age and
sex (3 years) to 77 of the controls (Table 3). The
association between OSCC and HIV infection was
Table 1. Characteristics of cases and controls in the initial case–
control data set.
Cases (n = 50)
n (%)
Controls (n = 50)
n (%) P
Sex M: F 36:14 36:14 1.000
Age mean (y) 56.2 56.1 0.856
Age below 45 years 14 (28) 16 (32) 0.828
Age below 60 years 28 (56) 29 (58) 1.000
Residence
Urban 25/49 (51) 18/47 (38) 0.226
Rural 24/49 (49) 29/47 (62)
Marital status
Married 33 (66) 34/49 (69) 0.831
Not married 17 (34) 15/49 (31)
Educational achievement
Primary or lower 27 (54) 20/48 (42)
Secondary or higher 23 (46) 28/48 (58) 0.234
Mean duration of
symptoms (weeks)
17.7 194 0.004
Cooking with
charcoal or firewood
34 (68) 18/48 (38) 0.004
Ever smoking 28 (56) 6/49 (12) <0.000
Current smoking 19 (38) 0/49 (0) <0.000
Ever alcohol 29 (48) 25/49 (51) 0.548
Current alcohol 19 (38) 11/49 (22) 0.123
Location of tumor
Upper third 11 (24)
Middle third 26 (28)
Lower third 9 (18)
Tumor classification
Well differentiated 3 (7)
Moderately
differentiated
4 (9)
Poorly differentiated 9 (20)
Unclassified 30 (65)
Esophageal occlusion
No occlusion 4 (9)
Partial occlusion 16 (37)
Complete occlusion 26 (53)
Denominators that are not exactly 50 have been indicated for clarity.
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stronger in patients below the age of 60 years (OR 6.3;
95% CI, 1.5–36.4; P = 0.006) (Table 3).
Discussion
In recent years we have observed a worrying trend of
increased occurrence of OSCC in young Zambian adults.
Identifying the risk factors for these cancers is clearly a
matter of great importance for gastroenterology in this
region of southern Africa, and may unlock important
clues to the etiopathogenesis of OSCC generally. In this
paper, we report an investigation into the association of
OSCC with various lifestyle risk factors, and the possible
influence of HIV and HPV infection on the occurrence of
OSCC among Zambian adults. We found that HIV infec-
tion independently increased the odds of developing
OSCC. We further found that the use of firewood or
charcoal as a means of cooking in the home, and cigarette
smoking but not alcohol intake, increased the odds of
developing OSCC. HPV infection does not appear to
explain the occurrence of OSCC in Zambian adults.
The prevalence of HIV infection in the Zambian popu-
lation is high (12.5% in very recent data) [10]. There
have been reports suggesting an increased risk of esopha-
geal cancer among people living with HIV infection [11,
23], although this has not been systematically investigated
in areas heavily affected by HIV. Our initial analysis of 50
cases and 50 controls suggested an effect of borderline
significance on multivariate analysis and in younger
adults. Therefore, we decided to include data collected
earlier in a similar case–control study conducted at the
same unit. This increased the number of cancer cases to
77 and the results confirmed that HIV is associated with
OSCC.
There is no clear consensus on the role of HPV in the
development of esophageal cancer. Results from different
studies have been inconsistent; Syrj€anen et al. suggested
that this could be because of geographic variations in the
populations being studied [24]. There is no baseline
information on the prevalence of esophageal HPV infec-
tion in Zambia, but our results suggest that it is low and
does not play a large role in the development of OSCC.
Our findings are consistent with some studies from
around the region, such as one from Kenya which showed
that there was no HPV isolated in any of the esophageal
cancer specimens evaluated [25]. Therefore, unlike the sit-
uation in cervical cancer, HPV does not appear to explain
the association between HIV and OSCC in younger
Table 2. Lifestyle and biological risk factors of squamous cell cancer of the esophagus in the initial case–control data set.
Cases n (%) Controls n (%)
Univariate Multivariable1
OR 95% (CI) P OR 95% (CI) P
HIV infection (serology) 11/49 (22) 8/49 (16) 1.5 (0.5–4.7) 0.610 2.8 (0.8–9.5) 0.092
HIV infection in patients less than 60 years 8/27 (30) 2/28 (7) 5.5 (0.9–56.9) 0.040 5.5 (1.0–27.7) 0.045
HPV infection (PCR) 2/44 (5) 1/48 (2) 2.2 (0.8–5.7) 0.605 2.2 (0.1–41.0) 0.596
Cooking with charcoal or firewood 34/50 (68) 18/48 (38) 3.5 (1.4–9.3) 0.004 3.0 (1.2–7.4) 0.021
Ever smoking 28/50 (56) 6/49 (12) 9.1 (3.0–30.4) <0.000 8.0 (2.8–22.7) <0.000
Current smoking 19/50 (38) 0/49 (0) – <0.000 – –
Ever alcohol 29/50 (58) 25/49 (51) 1.3 (0.6–3.2) 0.548 0.3 (0.8–1.0) 0.057
Current alcohol 19/50 (38) 11/49 (22) 2.1 (0.8–5.7) 0.123 3.8 (0.8–18.1) 0.090
PCR, polymerase chain reaction; OSCC, esophageal squamous cell carcinoma; HIV, human immunodeficiency virus; HPV, human papillomavirus.
1For the multivarible analysis, we included all the variables that could possibly be risk factors for OSCC. These included smoking, alcohol intake,
HIV and HPV infection, exposure to household smoke, educational level, residence, marital status and occupation.
Table 3. Human immunodeficiency virus as a risk factor for squamous cell carcinoma (combined data from the current study and from a previous
case–control study).
Age Cases n (%) Controls n (%) OR 95% (CI) P
Entire data set
All 18/77 (23) 17/145 (12) 2.3 (1.0–5.1) 0.03
Less than 60 years 14/43 (33) 8/80 (10) 4.3 (1.5–13.2) 0.003
Matched by age (3 years) and sex1
All 18/77 (23) 8/77 (10) 2.6 (0.1–7.5) 0.05
Less than 60 years 14/43 (33) 3/42 (7) 6.3 (1.5–36.4) 0.006
1Analysis with McNemar’s test, the results for all ages and those less than 60 years were similar: (OR 2.3; 95% CI, 1.01–5.01; P = 0.04) and (OR
4.7; 95% CI, 1.45–15.1; P = 0.005), respectively.
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adults. Disappointingly, these data suggest that wide-
spread HPV immunization will not reverse the secular
trend towards developing OSCC in young adults.
Exposure to wood smoke has previously been reported
to increase the risk of developing esophageal cancer. In a
study involving 99 cases and 223 controls in Brazil, expo-
sure to woodstoves was found to increase the risk of
esophageal cancer (OR 4.42; P < 0.001) [26]. A recently
published study from Kenya showed that poor socio-
economic status and cooking with charcoal or firewood
were risk factors for developing esophageal cancer [27].
In the current study, we found that using firewood and
charcoal for cooking in the home increases the odds of
developing SCC. Zambia is an underdeveloped country
with an estimated 80% of its population living in poverty.
Only 19% of Zambian households have electricity, includ-
ing 48% in urban and 3% in rural areas [28]. Up to 41%
of households in Zambia cook outdoors, again more in
the rural (92%) than urban areas (37%). Firewood and
charcoal are the most commonly used fuel for cooking in
households without electricity, and rural areas rely mainly
on firewood. These statistics show that a large proportion
of Zambians are exposed to charcoal and firewood smoke
throughout their lives, but the health risks of this expo-
sure have not been ascertained. Exposure to inhaled wood
smoke could also explain the reported higher incidence of
esophageal cancer among people of low socio-economic
status. This requires further study, because it is not clear
from our data how this extra risk is mediated, whether by
inhalation, ingestion on cooked foodstuffs, or direct con-
tact with cooking utensils. We are inclined to believe that
this and other risks from wood smoke exposure during
cooking (respiratory disorders) could be avoided by wide-
spread introduction of alternative energy sources, but this
is beyond the scope of the present study.
Established risk factors for esophageal cancer include
smoking, alcohol [29–32] and advancing age [3]. Risk fac-
tors for adenocarcinoma include Barrett’s esophagus, obes-
ity and the use of anti-acids [4]. There are no published
data on the genetics and risk factors for OSCC in Zambia,
although in studies within the region (South Africa and
Uganda), smoking has been reported to play a major role
in esophageal cancer [3, 31, 33]. However, there is a need
to further evaluate the relationship between gene suscepti-
bility and lifestyle risk factors such as smoking [34]. We
found a highly significant association between cigarette
smoking and OSCC. We collected information on patients
who were still smoking at the time of enrollment and those
who had stopped smoking. None of the controls were cur-
rent smokers; therefore, we did not calculate the ORs or
include this variable in the multivariate analysis. However,
38% of cases smoked at the time of enrollment, a much
higher proportion of smoking than controls.
Reilly [35] reported a possible correlation between
esophageal cancer and the consumption of home-produced
alcoholic drinks in Zambia. However, we have not found
evidence in support of this, because neither current nor
past use of alcohol was associated with OSCC in our study.
This is the first study that prospectively collected data
on the age distribution of esophageal cancer patients in
Zambia, and we have found that 28% were below the age
of 45 years. This is similar to our previous findings in
gastric cancer cases in which 21% were below 45 years
[36], and an earlier retrospective report on esophageal
cancer in which it was 27% [7]. Taken together, these
data from one central, busy endoscopy unit indicate that
there is an emerging problem with gastrointestinal cancers
in young Zambian adults.
The outcome of esophageal cancer patients in limited
resource countries such as Zambia tends to be very poor.
One of the postulated reasons is due to late presentation
for medical assistance. For the 50 OSCC patients enrolled
into this study, their symptoms had been present for an
average of 17.7 weeks, ranging from 1 to 52 weeks. This
clearly shows that there is a need to sensitize this popula-
tion to seek medical assistance as soon as symptoms of dys-
phagia start to develop, to improve the treatment
outcomes.
In conclusion, HIV infection and exposure to domestic
and cigarette smoke are risk factors for OSCC. HPV
infection and the use of alcohol do not appear to play a
large role in OSCC in Zambia.
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